181 related articles for article (PubMed ID: 10462385)
21. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
[TBL] [Abstract][Full Text] [Related]
22. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance.
Humar A; Washburn K; Freeman R; Paya CV; Mouas H; Alecock E; Razonable RR;
Liver Transpl; 2007 Oct; 13(10):1422-7. PubMed ID: 17902128
[TBL] [Abstract][Full Text] [Related]
23. Post-transplant lymphoproliferative disorders in liver transplanted patients: a single-centre experience.
Marino D; Burra P; Boccagni P; Calabrese F; Canova F; Trentin C; Boso C; Soldà C; Angeli P; Aversa SM
Anticancer Res; 2010 Jun; 30(6):2383-91. PubMed ID: 20651397
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation.
Bigam DL; Pennington JJ; Carpentier A; Wanless IR; Hemming AW; Croxford R; Greig PD; Lilly LB; Heathcote JE; Levy GA; Cattral MS
Hepatology; 2000 Jul; 32(1):87-90. PubMed ID: 10869293
[TBL] [Abstract][Full Text] [Related]
25. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
[TBL] [Abstract][Full Text] [Related]
26. Key features distinguishing post-transplantation lymphoproliferative disorders and acute liver rejection.
Rizkalla KS; Asfar SK; McLean CA; Garcia BM; Wall WJ; Grant DR
Mod Pathol; 1997 Jul; 10(7):708-15. PubMed ID: 9237182
[TBL] [Abstract][Full Text] [Related]
27. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
28. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
29. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis.
Duvoux C; Tran Ngoc A; Intrator L; Hézode C; Germanidis G; Pawlotsky JM; Cherqui D; Dhumeaux D
Transpl Int; 2002 Jan; 15(1):3-9. PubMed ID: 11875606
[TBL] [Abstract][Full Text] [Related]
31. High rate of infection and immune disorders in patients with hepatitis C virus after liver transplantation.
Micheloud D; Salcedo M; Bañares R; Rincón D; Jensen J; Rodríguez JJ; Fernández-Cruz E; Carbone Campoverde J; Resino S
Transpl Infect Dis; 2009 Aug; 11(4):367-72. PubMed ID: 19497071
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C-related posttransplant plasma cell proliferative disorder with hepatitis C virus in neoplastic plasma cells: a new posttransplant disease entity?
Tun HW; Krishna M; Menke DM
Transplant Proc; 2004 Nov; 36(9):2692-6. PubMed ID: 15621126
[TBL] [Abstract][Full Text] [Related]
33. Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
Kim RD; Fujikawa T; Mizuno S; Schwartz JJ; Sorensen JB; Hemming AW; Fujita S
Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):559-65. PubMed ID: 21555941
[TBL] [Abstract][Full Text] [Related]
34. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
Johnson LR; Nalesnik MA; Swerdlow SH
Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
[TBL] [Abstract][Full Text] [Related]
35. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
[TBL] [Abstract][Full Text] [Related]
36. Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epstein-Barr virus infection.
Hori T; Oike F; Hata K; Nishikiori M; Ogura Y; Ogawa K; Takada Y; Egawa H; Nguyen JH; Uemoto S
Transpl Infect Dis; 2010 Aug; 12(4):347-52. PubMed ID: 20456713
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus reactivation is a risk factor for development of post-transplant lymphoproliferative disease after liver transplantation.
Zhang A; Zhang M; Shen Y; Wang W; Zheng S
Clin Transplant; 2009; 23(5):756-60. PubMed ID: 19664018
[TBL] [Abstract][Full Text] [Related]
38. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
Zekry A; Whiting P; Crawford DH; Angus PW; Jeffrey GP; Padbury RT; Gane EJ; McCaughan GW;
Liver Transpl; 2003 Apr; 9(4):339-47. PubMed ID: 12682883
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
[TBL] [Abstract][Full Text] [Related]
40. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Roque J; Rios G; Humeres R; Volpi C; Herrera JM; Schultz M; Rios H; Rius M; Salgado C; Hepp J
Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
